latentbrief
Back to news
Launch1d ago

AI Cuts Drug Development Time by Half

AI News1 min brief

In brief

  • Artificial intelligence is drastically speeding up the drug discovery process in China, according to Insilico Medicine's CEO Alex Zhavoronkov.
  • By combining AI with lab research, some drug candidates are now developed in just one year-down from a typical 13-month timeline.
  • The company's fastest project achieved its target in nine months.
    • This breakthrough matters because it could significantly reduce the time and cost of bringing new medicines to market.
  • For developers and researchers, this means more treatments can be tested quickly, potentially accelerating the discovery of life-saving drugs.
  • Looking ahead, Insilico Medicine plans to further refine its AI tools to improve accuracy and efficiency, aiming to set new standards in drug development globally.

Read full story at AI News

More briefs